The impact of the pandemic on alcohol-related liver disease and liver transplantation, and the emergence of non-alcohol related fatty liver disease (NAFLD) as a public health threat to be featured at International Liver Congress™ 2022 (ILC 2022)

The latest and 57th iteration of International Liver Congress™  (ILC 2022) returns as an in-person event in London this coming June (22–26). The event is being held at the ExCeL London exhibition centre, and online.  The congress is convened annually by the European Association Read More

EASL Statement on cases of severe acute hepatitis in children of unknown causes

The European Association for the Study of the Liver (EASL) echoes the concerns of UK and WHO Europe officials on this unusual outbreak of severe acute hepatitis in children, originally in Europe, and more recently in Asia and North America.  Read More

A-TANGO – An EU-funded clinical Phase II study gives cirrhosis patients new hope

More than ten million people worldwide suffer from decompensated cirrhosis, often as a result of severe alcoholic hepatitis (sAH) or other chronic liver diseases. In its final stages, decompensated cirrhosis leads to acute-on-chronic liver failure (ACLF), a syndrome characterised by Read More